antibiotic therapy

抗生素治疗
  • 文章类型: Journal Article
    在中国患有社区获得性肺炎(CAP)的成年人发病率很高。CAP是由多种病原体引起的;然而,通常缺乏针对病原体的临床症状。因此,缺乏准确微生物学诊断的患者接受经验性抗微生物药物治疗.
    我们收集了支气管肺泡灌洗液,以及湖北三家医院收治的650名成人CAP患者的临床和实验室数据,四川,和中国的浙江省。培养样本,并使用实时逆转录qPCR(RT-qPCR)测定法测试42种呼吸道细菌和病毒的存在。对CAP进行了地区调查,性别,以及感染或合并感染的年龄和模式。采用适合诊断的临床指南,我们回顾性评估了适当的病原体导向治疗,并将其与最初的经验性治疗进行了比较.
    我们的研究发现,21.38%(139/650)的患者被归类为严重CAP(S-CAP),男性患病率较高,老年人,在温暖的季节。35.53%(231/650)的病例检出细菌病原体。肺炎克雷伯菌,流感嗜血杆菌,金黄色葡萄球菌是不同人口统计学和地区最普遍的细菌。在48.76%(317/650)的患者中发现了病毒病原体,人类鼻病毒,巨细胞病毒是最常见的病毒。24.31%(158/650)的病例存在合并感染,病毒-细菌共感染是最常见的。与标准培养方法相比,RT-qPCR对关键病原体的检测率明显更高。通过允许18.30%(95/518)的患者降级,它显示了优化抗菌药物处方的潜力,其中减少过量抗生素的数量主要包括减少第二代或第三代头孢菌素的使用(5.79%,30/518)和β-内酰胺酶抑制剂组合。
    该研究强调了S-CAP的重大负担,特别是在特定的人口统计和季节。细菌和病毒病原体的流行,伴随着高感染率,强调需要全面的诊断方法。RT-qPCR检测是一种卓越的诊断工具,提供增强的病原体检测能力和促进更精确的抗菌治疗。这可以改善患者的预后,并有助于合理使用抗菌药物,解决日益增长的抗生素耐药性问题。
    UNASSIGNED: Adults with community-acquired pneumonia (CAP) in China suffer high morbidity. CAP is caused by a multitude of pathogens; however, pathogen-directed clinical symptoms are often lacking. Therefore, patients lacking an accurate microbiological diagnosis are administered with empirical antimicrobials.
    UNASSIGNED: We collected bronchoalveolar lavage fluid, as well as clinical and laboratory data from 650 adult patients with CAP admitted to three hospitals in Hubei, Sichuan, and Zhejiang provinces in China. Specimens were cultured and tested using real-time reverse transcription qPCR (RT-qPCR) assays for the presence of 42 respiratory bacteria and viruses. CAP was investigated with respect to regions, genders, and age and patterns of infections or co-infections. Employing clinical guidelines adapted for diagnosis, we assessed retrospectively the appropriate pathogen-directed therapy and compared it with the initial empirical therapies.
    UNASSIGNED: Our study identified that 21.38% (139/650) of the patients were classified as having Severe CAP (S-CAP), with a higher prevalence among males, older adults, and during the warm season. Bacterial pathogens were detected in 35.53% (231/650) of cases. K. pneumoniae, H. influenzae, and S. aureus were the most prevalent bacteria across different demographics and regions. Viral pathogens were found in 48.76% (317/650) of patients Epstein-Barr, Human rhinovirus, and Cytomegalovirus were the most common viruses. Co-infections were present in 24.31% (158/650) of cases, with viral-bacterial co-infections being the most frequent. The RT-qPCR demonstrated significantly higher detection rates for key pathogens compared to standard culture methods. It showed potential in optimizing antimicrobial prescriptions by allowing for de-escalation in 18.30% (95/518) of patients, among which reducing the number of excessive antibiotics mainly comprised decreasing the use of 2nd or 3rd generation cephalosporins (5.79%, 30/518) and β-lactamase inhibitor combinations.
    UNASSIGNED: The study highlights the significant burden of S-CAP, particularly among specific demographics and seasons. The prevalence of bacterial and viral pathogens, along with the high rate of co-infections, emphasizes the need for comprehensive diagnostic approaches. The RT-qPCR assays emerge as a superior diagnostic tool, offering enhanced pathogen detection capabilities and facilitating more precise antimicrobial therapy. This could lead to improved patient outcomes and contribute to the rational use of antimicrobials, addressing the growing concern of antibiotic resistance.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    由多重耐药生物体如肺炎克雷伯菌引起的血流感染是管理血液恶性肿瘤的重大挑战。本研究旨在描述肺炎克雷伯菌血流感染的流行病学特征,特别是在血液系统恶性肿瘤患者中,描绘初始抗生素治疗的模式,评估耐药菌株的患病率,确定这些耐药菌株的风险因素,并评估影响患者预后的因素。回顾性分析2017年1月至2020年12月在单个中心进行的,重点是182例发生肺炎克雷伯菌血流感染的血液恶性肿瘤患者。我们比较了接受适当和不适当抗生素治疗的患者30天死亡率,包括单药和联合治疗的有效性。采用Kaplan-Meier生存分析和多因素logistic和Cox回归分析确定影响死亡风险的因素。所有患者30天全因死亡率为30.2%。在接受不适当的初始治疗和适当的初始治疗的患者中,30天全因死亡率分别为77.2%和8.8%(p<0.001)。不适当的初始治疗显着影响死亡率,并且是30天死亡率的关键预测指标。以及感染性休克和以前的重症监护病房(ICU)。与CSKP组相比,耐碳青霉烯类肺炎克雷伯菌(CRKP)血流感染的患者表现出更严重的临床症状。该研究表明,碳青霉烯的经验性给药与CRKP和多药耐药肺炎克雷伯菌(MDR-KP)感染的患病率上升之间存在显着关联。此外,该研究发现初始抗生素治疗不适当,感染性休克,和入住ICU是30天死亡率的独立危险因素。
    Bloodstream infections caused by multidrug-resistant organisms such as Klebsiella pneumoniae are a significant challenge in managing hematological malignancies. This study aims to characterize the epidemiology of Klebsiella pneumoniae bloodstream infections specifically in patients with hematological malignancies, delineate the patterns of initial antibiotic therapy, assess the prevalence of resistant strains, identify risk factors for these resistant strains, and evaluate factors influencing patient outcomes. A retrospective analysis was conducted at a single center from January 2017 to December 2020, focusing on 182 patients with hematological malignancies who developed Klebsiella pneumoniae bloodstream infections. We compared the 30-day mortality rates between patients receiving appropriate and inappropriate antibiotic treatments, including the effectiveness of both single-drug and combination therapies. Kaplan-Meier survival analysis and multivariate logistic and Cox regression were used to identify factors influencing mortality risk. The 30-day all-cause mortality rate was 30.2% for all patients. The 30-day all-cause mortality rates were 77.2% and 8.8% in patients who received inappropriate initial treatment and appropriate initial treatment (p < 0.001). Inappropriate initial treatment significantly influenced mortality and was a key predictor of 30-day mortality, along with septic shock and previous intensive care unit (ICU) stays. Patients with carbapenem-resistant Klebsiella pneumoniae (CRKP) bloodstream infections exhibited more severe clinical symptoms compared to the CSKP group. The study demonstrates a significant association between empirical carbapenem administration and the escalating prevalence of CRKP and multidrug-resistant K. pneumoniae (MDR-KP) infections. Furthermore, the study identified inappropriate initial antibiotic therapy, septic shock, and ICU admission as independent risk factors for 30-day mortality.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    Lemierre综合征(LS)是一种罕见且危及生命的疾病,主要由坏死梭杆菌引起。目前,目前尚无针对LS管理的标准化临床指南.这里,我们描述了一个40岁男性发烧的案例,生产性咳嗽,呼吸困难但没有喉咙痛.诊断性放射学检查显示多个肺空洞结节和颈内静脉阻塞。肺泡灌洗液的宏基因组下一代测序(mNGS)鉴定了坏死梭杆菌,从而确认LS的诊断。有趣的是,尽管接受了适当的抗生素,患者仍表现出延迟的临床反应.在将替加环素整合到治疗中以解决潜在的共同感染细菌后,我们观察到他的临床症状明显改善。出院后12周的后续随访显示症状完全缓解,胸部CT扫描显示肺部病变明显消退。
    Lemierre syndrome (LS) is a rare and life-threatening condition predominantly caused by Fusobacterium necrophorum. Currently, there are no standardized clinical guidelines for LS management. Here, we describe the case of a 40-year-old male with fever, productive cough, and dyspnea but no sore throat. Diagnostic radiological examinations revealed multiple pulmonary cavitary nodules and an internal jugular vein occlusion. Metagenomic Next-Generation Sequencing (mNGS) of the alveolar lavage fluid identified Fusobacterium necrophorum, thereby confirming the diagnosis of LS. Intriguingly, the patient exhibited a delayed clinical response despite receiving the appropriate antibiotic. After integrating tigecycline into the treatment to address potential co-infecting bacteria, we observed a marked improvement in his clinical symptoms. Subsequent follow-up over 12 weeks post-discharge revealed complete alleviation of symptoms, and a chest CT scan showed marked regression of the lung lesions.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    近几十年来,非结核分枝杆菌(NTM)感染的发病率大幅上升.然而,全球NTM的诊断和管理面临重大挑战,特别是在涉及脓肿分枝杆菌复合体(MABC)感染的病例中,有效的治疗选择有限。
    我们报道了一名38岁的女性患者,因美容院的“美容针”而感染了MABC的皮肤,双颊上有肿块,伴随着红肿,和痛苦,其中一些被切除了。从双侧脸颊肿块多次穿刺抽脓,用“甲硝唑”冲洗,口服“头孢菌素”治疗无效。因此,她来到我们医院。通过核酸质谱检测脓肿穿刺脓液中的MABC,并由脓液的培养结果证明。因此,患者被诊断为皮肤MABC感染,并采取抗NTM治疗。然而,不良反应,如耳鸣,在初始治疗期间发生肝毒性和神经毒性。在调整到含有康奈唑胺的方案后,这些不良反应有所改善。经过近6个月的治疗,面颊肿块逐渐减少,皮肤破裂逐渐愈合。随访10个月,患者面部症状明显改善,无药物相关不良反应发生。
    这是使用含有康奈唑胺的抗生素管理策略治疗的皮肤多重耐药性MABC感染的首例成功病例,在这种顽固性疾病中表现出显著的疗效和良好的安全性。
    UNASSIGNED: In recent decades, there has been a substantial surge in the incidence of non-tuberculous Mycobacteria (NTM) infections. However, the diagnosis and management of NTM globally present significant challenges, particularly in cases involving Mycobacterium abscessus complex (MABC) infection where effective therapeutic options are limited.
    UNASSIGNED: We reported a 38-year-old female patient who was infected with MABC of skin due to \"beauty needle\" at a beauty salon, with mass on both cheeks, accompanied by redness, and pain, and some of them was ulcered and effused. Puncture pumping pus from bilateral cheek mass for many times, rinsed with \"metronidazole\", and oral \"cephalosporin\" treatment did not work. Therefore, she came to our hospital. MABC was detected in abscess paracentesis pus by nucleic acid mass spectrometry, and was proved by the cultured result of the pus. Thus, the patient was diagnosed as skin MABC infection, and anti-NTM treatment was taken. However, adverse reactions such as tinnitus, hepatotoxicity and neurovirulence occurred during the initial treatment. After adjusting to the contezolid-containing regimen, these adverse reactions improved. After nearly 6 months of treatment, the cheek mass was gradually reduced and the skin ruptures were gradually healed. Follow-up for 10 months showed that the patient\'s facial symptoms were significantly improved, and no drug-related adverse reactions happened.
    UNASSIGNED: This was the first successful case of multiple drug resistance MABC infection of skin treated with contezolid-containing antibiotic management strategies, which exhibited remarkable efficacy and good safety in this intractable disease.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目前,传统的分析方法存在操作复杂、昂贵的设备,和漫长的测试时间。电化学传感器已显示出巨大的优势和作为替代解决方案的应用潜力。在这项研究中,我们提出了一种新型的半自动电化学传感器阵列(SAESA)平台。使用具有管状设计的丝网印刷技术制造传感器阵列,其中所有电极都印刷在内壁上。管状传感器阵列与移液管的集成允许半自动化过程,包括采样和冲洗,这简化了操作,减少了整体时间。管状传感器阵列中的每个工作电极都经历了不同的装饰,以获得针对混合环境中的目标分析物的特定感测响应(例如,血液样本)。为了证明开发的传感平台对同时多分析物检测的适用性,我们选择抗生素治疗炎性感染作为模型方案,并连续测量三种生物标志物,即,替加环素(TGC),降钙素原(PCT),丙氨酸转氨酶(ALT)。检出限为0.3μM,0.3ng/L,和2.76U/L,分别。开发的半自动电化学传感器阵列具有快速,简单的操作等特点,便携性,良好的选择性,和出色的稳定性。
    At present, traditional analytical methods suffer from issues such as complex operation, expensive equipment, and a lengthy testing time. Electrochemical sensors have shown great advantages and application potential as an alternative solution. In this study, we proposed a novel semiautomated electrochemical sensor array (SAESA) platform. The sensor array was fabricated using screen-printed technology with a tubular design where all electrodes were printed on the inner wall. The integration of the tubular sensor array with a pipet allows for a semiautomated process including sampling and rinsing, which simplifies operation and reduces overall time. Each working electrode in the tubular sensor array underwent distinct decoration to get specific sensing responses toward the target analytes in a mixture environment (e.g., blood samples). To demonstrate the applicability of the developed sensing platform for simultaneous multianalyte detection, we chose antibiotic treatment for inflammatory infection as a model scenario and continuously measured three biomarkers, namely, tigecycline (TGC), procalcitonin (PCT), and alanine aminotransferase (ALT). The detection limits were 0.3 μM, 0.3 ng/L, and 2.76 U/L, respectively. The developed semiautomated electrochemical sensor array exhibits characteristics such as rapid and simple operation, portability, good selectivity, and excellent stability.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Letter
    外科医生在日常实践中处于预防和管理感染的最前沿。然而,在外科医生中,感染预防和管理的适当措施往往被忽视。缺乏对感染和预防措施的认识使外科医生从这场战斗中边缘化。一起,全球外科感染联盟(GAIS),世界急诊外科学会(WSES),外科感染学会(SIS),欧洲外科感染学会(SIS-E),世界外科感染学会(WSIS),美国创伤外科协会(AAST),和泛美创伤协会(PTS)共同完成了一项国际宣言,强调全球抗菌素耐药性构成的威胁,以及在整个手术途径中适当预防和管理感染的必要性。代表这些外科协会的作者呼吁世界各地的所有外科医生参与这一全球事业,承诺支持这一声明,以维持当前和未来抗生素的有效性。
    Surgeons in their daily practice are at the forefront in preventing and managing infections. However, among surgeons, appropriate measures of infection prevention and management are often disregarded. The lack of awareness of infection and prevention measures has marginalized surgeons from this battle. Together, the Global Alliance for Infections in Surgery (GAIS), the World Society of Emergency Surgery (WSES), the Surgical Infection Society (SIS), the Surgical Infection Society-Europe (SIS-E), the World Surgical Infection Society (WSIS), the American Association for the Surgery of Trauma (AAST), and the Panamerican Trauma Society (PTS) have jointly completed an international declaration, highlighting the threat posed by antimicrobial resistance globally and the need for preventing and managing infections appropriately across the surgical pathway. The authors representing these surgical societies call all surgeons around the world to participate in this global cause by pledging support for this declaration for maintaining the effectiveness of current and future antibiotics.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    急性痰胃炎(APG),一种罕见的临床状况,其主要特征是细菌侵入胃壁,并与高死亡率相关。APG的症状包括腹痛,恶心,呕吐,发烧,和感染。值得注意的是,临床表现缺乏特异性给疾病的早期诊断带来了挑战.APG通常在成年人中普遍存在,男性发病率高于女性。然而,其他年龄的患者也可能受到影响。我们在此提供一例12岁女孩因胃肠道症状和发烧入院的病例报告。患者的影像学检查结果与APG相符。尽管大多数痰质胃炎病例需要手术治疗,我们的患者通过影像学检查和抗生素治疗迅速好转.该病例证明了抗生素治疗早期诊断的成功。
    Acute phlegmonous gastritis (APG), a rare clinical condition, is mainly characterized by bacterial invasion in the gastric lining and is associated with a high mortality rate. The symptoms of APG include abdominal pain, nausea, vomiting, fever, and infection. Notably, the lack of specificity in the clinical presentation presents challenges in the early diagnosis of the disease. APG is often prevalent in adults, with a higher incidence in men than women. However, patients of other ages may also be affected. We herein present a case report of a 12-year-old girl who was admitted to the hospital with gastrointestinal symptoms and fever. The patient\'s imaging findings were compatible with APG. Despite the requirement for surgical treatment in most cases of phlegmonous gastritis, our patient rapidly improved with imaging and antibiotic therapy. This case demonstrates the success of antibiotic therapy with early diagnosis.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Review
    结核病(TB)是造血干细胞移植(HSCT)受者中一种罕见但具有潜在破坏性的并发症。恶性血液病患者应谨慎使用骨髓抑制相关抗生素。尤其是接受骨髓移植和骨髓抑制治疗的患者。尽管利奈唑胺已成为治疗严重结核病的推荐药物,其血液学毒性仍是其临床应用的障碍。康替唑胺是恶唑烷酮类化合物的新代表,在临床上,表现出优越的抗感染功效,但是没有关于HSCT后结核病治疗的报道。
    我们报道了1例急性淋巴细胞白血病患者HSCT后并发肺结核感染。在抗结核治疗期间,患者对含利奈唑胺的治疗方案反应不佳,并产生副作用,如牙龈出血和血小板减少症,所以药物改用了康奈唑胺.连续治疗15天后,患者的血小板增加到58×109/L,他出院了,情况稳定。在随后的抗结核治疗中,使用康奈唑胺治疗超过7个月,血小板保持稳定,无血液学不良反应及周围神经病变症状。此外,重复成像显示双肺病灶明显缩小,为患者提供良好的预后。
    这是首例成功的HSCT后结核病患者使用含有康奈唑胺的抗生素管理策略治疗,在这种致命的疾病中表现出显著的疗效和良好的安全性。
    Tuberculosis (TB) is a rare but potentially devastating complication in hematopoietic stem cell transplantation (HSCT) recipients. Myelosuppression-related antibiotics should be used cautiously in patients with hematological malignancies, especially those undergoing bone marrow transplantation and receiving bone marrow suppression therapy. Although linezolid has become the recommended drug for severe TB, its hematological toxicity is still an obstacle to its clinical application. Contezolid is a new representative of oxazolidinones in clinical development, showing superior anti-infection efficacy, but there have been no reports on the treatment of post-HSCT TB.
    We reported a patient with acute lymphoblastic leukemia suffered from pulmonary TB infection after HSCT. During anti-TB treatment, the patient had a poor response to linezolid-containing regimen, and developed side effects such as gingival bleeding and thrombocytopenia, so the administration was switched to contezolid. After 15 days of continuous treatment, the patient\'s platelet increased to 58×109/L, and he was discharged in stable condition. During subsequent anti-TB treatment with contezolid for more than 7 months, the platelets remained stable, and no hematological adverse reactions and no symptoms of peripheral neuropathy were observed. Moreover, repeat imaging showed that the bilateral lung lesions were significantly reduced, indicating a good outcome for the patient.
    This was the first successful case of post-HSCT TB patients treated with contezolid-containing antibiotic management strategies, which exhibited remarkable efficacy and good safety in this deadly disease.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Review
    我们报告了一例患有糖尿病和胆总管结石症的妇女,她低烧,发冷,严重虚弱7天。患者腹部压痛呈阳性。计算机断层扫描和磁共振成像显示肝脏中有一个巨大的脓肿。通过基于纳米孔的宏基因组第三代测序结合抗生素敏感性试验,在肝脏的化脓液中发现了高毒力肺炎克雷伯菌产生的超广谱β-内酰胺酶。患者经静脉抗生素治疗和经皮引流后康复。有糖尿病和胆总管结石病史的患者应意识到由高毒力肺炎克雷伯菌引起的化脓性肝脓肿的可能性。为了迅速控制这种疾病的发展,基于纳米孔的宏基因组第三代测序不仅在快速识别病原体、还可以指导抗生素的使用。
    We report a case of a woman with diabetes mellitus and choledocholithiasis who had a low fever with chills and severe weakness for 7 days. The patient\'s abdominal tenderness was positive. Computed tomography and magnetic resonance imaging showed a giant abscess in the liver. The production of extended-spectrum β-lactamases by hypervirulent Klebsiella pneumoniae was found in the purulent fluid of the liver by nanopore-based metagenomic third-generation sequencing combined with an antibiotic susceptibility test. The patient recovered after intravenous antibiotic therapy and percutaneous drainage. Patients with a history of diabetes mellitus and choledocholithiasis should be aware of the possibility of pyogenic liver abscesses caused by hypervirulent Klebsiella pneumoniae. To rapidly control the development of this disease, nanopore-based metagenomic third-generation sequencing plays an important role not only in rapidly identifying pathogens, but also in guiding the use of antibiotics.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    目的:我们报告一例表皮葡萄球菌植入式结晶体(ICL)培养阳性眼内炎的治疗成功。
    方法:一名18岁女性在植入ICL后20天出现左眼视力下降。根据检查和超声检查诊断术后眼内炎。取了玻璃体水龙头,和玻璃体内抗生素(万古霉素1mg/0.1ml和头孢他啶2mg/0.1ml)给药两次(每72小时),第二次玻璃体内注射四天后,球周注射曲安奈德。玻璃体培养证实了表皮葡萄球菌。眼内炎缓解了,视力从第7天的6/20提高到12/20,第38天的22/20。这是V4c模型中无ICL外植体和玻璃体切除术的ICL手术后表皮葡萄球菌眼内炎的第一个成功的医学解决方案。
    结论:在抗生素治疗中,该眼内炎患者的良好依从性和密切随访使术后对抗生素治疗的效果进行了仔细的监测,避免去除ICL或失去眼睛的完整性。术前咨询中应充分考虑ICL术后潜在感染性眼内炎的风险。
    OBJECTIVE: We report a case of successful medical management of endophthalmitis post implantable collamer lens (ICL) culture-positive of Staphylococcus epidermidis.
    METHODS: A 18-year-old female presented with decreased visual acuity in the left eye 20 days after ICL implantation. A diagnosis of postoperative endophthalmitis was made based on examination and ultrasonography. A vitreous tap was taken, and intravitreal antibiotics (vancomycin 1 mg/0.1ml and ceftazidime 2 mg/0.1ml) were administered twice (every 72 h), and peribulbar injection of triamcinolone acetonide after four days of the second intravitreal injection. The vitreous culture was confirmed for Staphylococcus epidermidis. The endophthalmitis was resolved, and visual acuity improved from 6/20 to 12/20 on day 7 and 22/20 on day 38. This is the first successful medical resolution of Staphylococcus epidermidis endophthalmitis post ICL surgery without ICL explantation and vitrectomy in the V4c model.
    CONCLUSIONS: In antibiotic therapy, the excellent compliance and close follow-up of this endophthalmitis patient enabled careful postoperative surveillance on the effect of antibiotic therapy, avoiding the removal of the ICL or the loss of the integrity of the eye. The risk of potential infectious endophthalmitis post-ICL surgery should be fully emphasized during preoperative counseling.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号